Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 6,7-dihydro-5,8-dimethyl-9-fluoro-1-oxo-1h,5h-benzo(i,j)quinolizine-2-carboxylic Acid
2. S 25930
3. S-25930
1. Ibafloxacine
2. 91618-36-9
3. Ibaflin
4. R-835
5. S-25930
6. R835
7. 53vpk9r0t5
8. R 835
9. R835;s25930
10. S25930
11. 9-fluoro-6,7-dihydro-5,8-dimethyl-1-oxo-1h,5h-benzo(ij)quinolizine-2-carboxylic Acid
12. S 25930
13. Ibafloxacino
14. Ibafloxacinum
15. 1h,5h-benzo(ij)quinolizine-2-carboxylic Acid, 9-fluoro-6,7-dihydro-5,8-dimethyl-1-oxo-
16. Ibafloxacine [inn-french]
17. Ibafloxacinum [inn-latin]
18. Ibafloxacino [inn-spanish]
19. Unii-53vpk9r0t5
20. Ibafloxacin [usan:inn:ban]
21. 1h,5h-benzo[ij]quinolizine-2-carboxylic Acid, 9-fluoro-6,7-dihydro-5,8-dimethyl-1-oxo-
22. Ibafloxacin [mi]
23. Ibafloxacin [inn]
24. Ibafloxacin (usan/inn)
25. Ibafloxacin [usan]
26. Dsstox_cid_31642
27. Dsstox_rid_97526
28. Ibafloxacin [mart.]
29. Dsstox_gsid_57853
30. Schembl154637
31. Chembl170052
32. Dtxsid8057853
33. Gtpl10819
34. Tox21_113686
35. Hy-u00214
36. Cs-7344
37. Fluoro-dimethyl-oxo-[?]carboxylic Acid
38. 6,7-dihydro-5,8-dimethyl-9-fluoro-1-oxo-1h,5h-benzo[ij]quinolizine-2-carboxylic Acid
39. Ibafloxacin [ema Epar Veterinary]
40. Ncgc00249910-01
41. Cas-91618-36-9
42. D04485
43. Q5983609
44. 6,7-dihydro-5,8-dimethyl-9- Fluoro-1-oxo-1h,5h-benzo[ij]quinolizine-2-carboxylic Acid
45. 7-fluoro-8,12-dimethyl-4-oxo-1-azatricyclo[7.3.1.05,13]trideca-2,5,7,9(13)-tetraene-3-carboxylic Acid
| Molecular Weight | 275.27 g/mol |
|---|---|
| Molecular Formula | C15H14FNO3 |
| XLogP3 | 3.3 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 5 |
| Rotatable Bond Count | 1 |
| Exact Mass | 275.09577147 g/mol |
| Monoisotopic Mass | 275.09577147 g/mol |
| Topological Polar Surface Area | 57.6 Ų |
| Heavy Atom Count | 20 |
| Formal Charge | 0 |
| Complexity | 490 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 1 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
* Dogs: :
Ibaflin is indicated for the treatment of the following conditions in dogs:
- dermal infections (pyoderma - superficial and deep, wounds, abscesses) caused by susceptible strains of Staphylococci, Escherichia coli and Proteus mirabilis;
- acute, uncomplicated urinary-tract infections, caused by susceptible strains of Staphylococci, Proteus species, Enterobacter spp. , E. coli and Klebsiella spp. ;
- respiratory-tract infections (upper tract) caused by susceptible strains of Staphylococci, E. coli, and Klebsiella spp.
Ibaflin gel is indicated in dogs for the treatment of the following conditions:
- dermal infections (pyoderma - superficial and deep, wounds, abscesses) caused by susceptible pathogens such as Staphylococcus spp. , E. coli and P. mirabilis.
* Cats: :
Ibaflin gel is indicated in cats for treatment of the following conditions:
- dermal infections (soft-tissue infections - wounds, abscesses) caused by susceptible pathogens such as Staphylococcus spp. , E. coli, Proteus spp. and Pasteurella spp. ;
- upper respiratory-tract infections caused by susceptible pathogens such as Staphylococcus spp. , E. coli, Klebsiella spp. and Pasteurella spp.
QJ01MA96
ABOUT THIS PAGE
50
PharmaCompass offers a list of Ibafloxacin API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Ibafloxacin manufacturer or Ibafloxacin supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Ibafloxacin manufacturer or Ibafloxacin supplier.
PharmaCompass also assists you with knowing the Ibafloxacin API Price utilized in the formulation of products. Ibafloxacin API Price is not always fixed or binding as the Ibafloxacin Price is obtained through a variety of data sources. The Ibafloxacin Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A DSSTox_CID_31642 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of DSSTox_CID_31642, including repackagers and relabelers. The FDA regulates DSSTox_CID_31642 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. DSSTox_CID_31642 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A DSSTox_CID_31642 supplier is an individual or a company that provides DSSTox_CID_31642 active pharmaceutical ingredient (API) or DSSTox_CID_31642 finished formulations upon request. The DSSTox_CID_31642 suppliers may include DSSTox_CID_31642 API manufacturers, exporters, distributors and traders.
DSSTox_CID_31642 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of DSSTox_CID_31642 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right DSSTox_CID_31642 GMP manufacturer or DSSTox_CID_31642 GMP API supplier for your needs.
A DSSTox_CID_31642 CoA (Certificate of Analysis) is a formal document that attests to DSSTox_CID_31642's compliance with DSSTox_CID_31642 specifications and serves as a tool for batch-level quality control.
DSSTox_CID_31642 CoA mostly includes findings from lab analyses of a specific batch. For each DSSTox_CID_31642 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
DSSTox_CID_31642 may be tested according to a variety of international standards, such as European Pharmacopoeia (DSSTox_CID_31642 EP), DSSTox_CID_31642 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (DSSTox_CID_31642 USP).
